Company · CIK 0001737287 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Allogene Therapeutics, Inc. · ALLO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 SForm 4 → | Aug 25, 4:43 pm EDT | Earl Martin DouglasSVP, General Counsel | 29,697 | $2.12 | $62,958 | 488,267 | −5.73% | |
| Jun 18, 2026 MForm 4 → | Jun 23, 4:35 pm EDT | Joshua A KazamDirector | 47,700 | — | — | 398,463 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 AForm 4 → | Jul 6, 5:51 pm EDT | Zachary RobertsPresident and CEO | 610,720 | — | — | 476,190 | — | |
| Jun 18, 2026 AMForm 4 → | Jun 23, 4:35 pm EDT | Joshua A KazamDirector | 143,100 | — | — | 95,400 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 4:34 pm EDT | Deborah M. MessemerDirector | 95,400 | — | — | 95,400 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 4:33 pm EDT | Stephen MayoDirector | 144,400 | — | — | 144,400 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 4:32 pm EDT | Vicki L SatoDirector | 95,400 | — | — | 95,400 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 4:29 pm EDT | Owen N. WitteDirector | 95,400 | — | — | 95,400 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 4:28 pm EDT | Franz B HumerDirector | 95,400 | — | — | 95,400 | — | |
| Jun 18, 2026 AForm 4 → | Jun 23, 4:26 pm EDT | Elizabeth A. BarrettDirector | 95,400 | — | — | 95,400 | — |